tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SLNO Stock Latest News

Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome
Press ReleasesSoleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome
9d ago
SLNO
Soleno Therapeutics submits NDA for DCCR extended-release tablets
PremiumThe Fly
Soleno Therapeutics submits NDA for DCCR extended-release tablets
9d ago
SLNO
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13d ago
SLNO
Soleno Therapeutics set to join Russell 3000 Index
PremiumThe Fly
Soleno Therapeutics set to join Russell 3000 Index
1M ago
SLNO
Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024
PremiumPress Releases
Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024
2M ago
SLNO
Soleno Therapeutics to Participate in Upcoming Investor Conferences
PremiumPress ReleasesSoleno Therapeutics to Participate in Upcoming Investor Conferences
2M ago
SLNO
Soleno Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Soleno Therapeutics management to meet with Piper Sandler
2M ago
SLNO
Soleno Therapeutics launches initiative in honor of PWS Awareness Day
PremiumThe Fly
Soleno Therapeutics launches initiative in honor of PWS Awareness Day
2M ago
SLNO
Soleno Therapeutics Stands with the Prader-Willi Syndrome Community
PremiumPress Releases
Soleno Therapeutics Stands with the Prader-Willi Syndrome Community
2M ago
SLNO
Soleno Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Soleno Therapeutics management to meet with Piper Sandler
2M ago
SLNO
Soleno Therapeutics price target lowered to $59 from $65 at Oppenheimer
PremiumThe Fly
Soleno Therapeutics price target lowered to $59 from $65 at Oppenheimer
2M ago
SLNO
Soleno Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Soleno Therapeutics management to meet with Piper Sandler
2M ago
SLNO
Soleno Therapeutics management to meet with Piper Sandler
PremiumThe FlySoleno Therapeutics management to meet with Piper Sandler
2M ago
SLNO
Soleno Therapeutics reports Q1 EPS (59c), consensus (37c)
PremiumThe Fly
Soleno Therapeutics reports Q1 EPS (59c), consensus (37c)
2M ago
SLNO
Soleno Therapeutics initiated with an Outperform at Baird
PremiumThe Fly
Soleno Therapeutics initiated with an Outperform at Baird
2M ago
SLNO
Soleno Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Soleno Therapeutics management to meet with Piper Sandler
2M ago
SLNO
Soleno Therapeutics 3M share Spot Secondary priced at $46.00
PremiumThe Fly
Soleno Therapeutics 3M share Spot Secondary priced at $46.00
2M ago
SLNO
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
PremiumPress Releases
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
2M ago
SLNO
Soleno Therapeutics 2.5M share Spot Secondary; price range $45.00-$46.00
PremiumThe Fly
Soleno Therapeutics 2.5M share Spot Secondary; price range $45.00-$46.00
2M ago
SLNO
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
PremiumPress ReleasesSoleno Therapeutics Announces Proposed Public Offering of Common Stock
2M ago
SLNO
Soleno Therapeutics files to sell common stock, no amount given
PremiumThe Fly
Soleno Therapeutics files to sell common stock, no amount given
2M ago
SLNO
Soleno Therapeutics announces publication of data comparing DCCR treatment
PremiumThe Fly
Soleno Therapeutics announces publication of data comparing DCCR treatment
2M ago
SLNO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >